|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-OPIOID RECEPTOR STIMULATION REDUCES
2-OPIOID RECEPTOR RESPONSES IN THE SA NODE
1 Integrative Physiology/Cardiovascular Research Instirute, University of North Texas Health Science Center, Fort Worth, Texas, United States
* To whom correspondence should be addressed. E-mail: caffreyj{at}hsc.unt.edu.
Ultra-low doses (fmoles/min) of methionine-enkephalin-arginine-phenylalanine (MEAP) improve vagal transmission (vagotonic) and decrease heart rate by stimulating
1-opioid receptors within the sinoatrial (SA) node. Higher doses of MEAP (nmoles/min) acting on
2-opioid receptors interrupt vagal transmission (vagolytic) and reduce the decline in heart rate. Preconditioning-like occlusion of the nodal artery produced a vagotonic response that was reversed by the
1-receptor antagonist BNTX. This study was designed to test the hypothesis that extended
1-opioid receptor stimulation reduces
2-opioid receptor responses. The vagi were isolated, ligated and the right vagus was stimulated to produce a two-step decline in heart rate. In study one, the
2-agonist, deltorphin II was introduced into the SA node by microdialysis to evaluate the
2-response before and after the infusion of the
1-agonist, TAN-67. TAN-67 reduced the vagolytic effect of deltorphin by two thirds. In study two, the selective
1-antagonist BNTX was combined with TAN-67. BNTX preserved the deltorphin response suggesting that attrition of the prior response was mediated by
1-receptor activity. When TAN 67 was omitted in time control studies, some loss of the
2-response was apparent in the absence of the
1-agonist. This loss was also eliminated by the
1-antagonist, BNTX suggesting that the attenuation following deltorphin was also due to
1-activity. Additional studies were conducted to determine the effect of TAN-67 in the absence of prior deltorphin. When time controls were conducted without the initial deltorphin treatment a robust vagolytic response was observed. When this same deltorphin was preceded by TAN 67, the vagolytic response was significantly eroded. BNTX infused after loss of the
2-response was unable to reverse the loss. These data support the conclusion that the loss of the
2-response resulted from reduced
2-activity mediated by continued
1-receptor stimulation and not the arithmetic consequence of increased competition from that same
1-activity
This article has been cited by other articles:
![]() |
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey Repeated Arterial Occlusion, Delta-Opioid Receptor (DOR) Plasticity and Vagal Transmission Within the Sinoatrial Node of the Anesthetized Dog Experimental Biology and Medicine, January 1, 2009; 234(1): 84 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Davis, S. H. Deo, M. Barlow, D. Yoshishige, M. Farias, and J. L. Caffrey The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of {delta}2-opioid receptor stimulation Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2318 - H2326. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |